AI Article Synopsis
- Despite advances in positron emission tomography, cardiac SPECT imaging remains popular due to its accessibility and widespread clinical application.
- CZT-based detectors offer improved imaging capabilities compared to traditional Anger type detectors, leading to successful clinical use since their introduction 15 years ago.
- Ongoing research into new semiconductor materials and the development of advanced SPECT systems indicate potential future advancements in nuclear cardiology.
Article Abstract
Despite recent developments in positron emission tomography technology, cardiac single photon emission computed tomography (SPECT) imaging continues to be the main stream of nuclear cardiology because of its high accessibility and wider clinical use. For SPECT imaging, cadmium-zinc telluride (CZT) based detectors have advantages over conventional Anger type detectors with more flexible camera design thanks to the small sized CZT detectors and high contrast imaging because of its high energy resolution. Approximately 15 years ago, CZT-based cardiac SPECT cameras became commercially available, resulting in great success in clinical practice. However, this was just the beginning of the CZT era. To date, CZT-based general purpose whole-body camera and 3 dimensional full-ring SPECT systems have been developed and become commercially available with promising initial results. Although there still are areas to be addressed before wider clinical use, the CZT-based technology may provide significant progresses in nuclear cardiology as new generation SPECT systems. Finally, newer materials for the semiconductor detectors are under investigation or development, suggesting that there will be more developments in cardiac SPECT technology.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11612397 | PMC |
| http://dx.doi.org/10.17996/anc.24-00011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[In]In-RM2: a high potential agent for SPECT imaging of GRPR-expressing tumors.
Phys Eng Sci Med
January 2025
Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, 14155-1339, Iran.
Gastrin-releasing peptide receptors (GRPRs) overexpressed in many cancers are known as promising biomarkers to target tumors such as prostate, breast, and lung cancers. As the early diagnosis of the cancers can serve for better treatment of the patients, [In]In-DOTA-Pip-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 ([In]In-RM2) was prepared using an in-house developed Sn/In generator. 0.
View Article and Find Full Text PDFChemical Probes for Investigating the Endocannabinoid System.
Curr Top Behav Neurosci
January 2025
Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Cannabis sativa has been used therapeutically since early civilizations, with key cannabinoids Δ-tetrahydrocannabinol (THC) 3.1 and cannabidiol characterized in the 1960s, leading to the discovery of cannabinoid receptors type 1 (CBR) and type 2 (CBR) and the endocannabinoid system (ECS) in the 1990s. The ECS, involving endogenous ligands like 2-arachidonoylglycerol (2-AG) 1.
View Article and Find Full Text PDFImproving the image quality of short-time bone SPECT using cadmium-zinc-telluride detectors with SwiftScan.
Asia Ocean J Nucl Med Biol
January 2025
Department of Nuclear Medicine, Saitama Medical University Hospital, Saitama, Japan.
Article Synopsis
- This study examined the effectiveness of bone SPECT imaging with and without SwiftScan technology in patients with prostate cancer bone metastases.
- Involving 10 patients and 130 metastatic lesions, the research compared the quality of images produced at various acquisition times, showcasing improved quality scores and correlation coefficients with SwiftScan.
- Findings indicated that SwiftScan allowed for a 50% reduction in acquisition time while still maintaining acceptable image quality and accurate quantitative measurements like SUV and contrast-to-noise ratios.
Exercise electrocardiogram combined with cadmium zinc tellurium (CZT) cardiac-dedicated single photon emission computed tomography (SPECT) predicts coronary artery disease.
Clin Radiol
December 2024
Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China. Electronic address:
Aim: Coronary artery disease (CAD) is a primary cause of mortality, prompting ongoing research into noninvasive diagnostic modalities. This study aimed to evaluate the diagnostic efficacy of exercise electrocardiography testing (EET) combined with cadmium zinc tellurium cardiac-dedicated single photon emission computed tomography (CZT-SPECT) imaging for CAD.
Materials And Methods: CZT-SPECT and EET were examined in 124 patients aged 20-85 years, followed by coronary angiography to evaluate the sensitivity, specificity, positive predictive value, and negative predictive value of EET/CZT-SPECT alone and in combination.
Study Objectives: To evaluate the capability and accuracy of magnetocardiography (MCG) to identify patients with ischemic chest pain from those with non-ischemic pain and to verify normalcy in the MCG in healthy subjects.
Design: We studied 133 patients (mean age 59 ± 14 years, 69 % male) with chronic or acute chest pain syndrome and 63 healthy subjects (mean age 41.7 ± 12.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!